OM1
OM1 is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 3 tracked investors.
About OM1
OM1 is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
OM1 provides an AI-driven healthcare outcomes platform and real-world data products, including the PhenOM foundation model, to identify patient phenotypes, predict medical events and enable regulatory-ready observational studies. It licenses enriched longitudinal datasets and offers analytics and consulting for life sciences, providers, and payers.
Explore OM1's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.